Peptide
KPV
The inflammation quieter
A tripeptide derived from alpha-MSH with potent anti-inflammatory properties. KPV has shown particular promise for gut inflammation and immune modulation without melanocortin receptor activation.
Mechanisms
- NF-kB inhibition
- Cytokine reduction
- Gut barrier support
- Anti-inflammatory signaling
Dosing
Typical dose
200–500mcg
Timing
Can be administered subcutaneously or orally. Often combined with BPC-157 for gut protocols.